Literature DB >> 20602249

Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of coronary artery disease.

Andy Tsapaki1, Apostolos Zaravinos, Stavros Apostolakis, Konstantinos Voudris, Konstantina Vogiatzi, Georgios E Kochiadakis, Demetrios A Spandidos.   

Abstract

Genetic polymorphy of the distal promoter region of the ST2 gene influences transcriptional activity and susceptibility to atopic dermatitis and asthma. Based on the inflammatory background of atherosclerosis we hypothesized that ST2 distal promoter genetic polymorphy could also affect susceptibility to coronary artery disease (CAD). To test our hypothesis we performed direct sequencing of a 825 bp locus of the distal promoter -with previously reported significant polymorphy in 63 angiographically diagnosed CAD patients and 63 age and sex matched controls with negative coronary angiography. We identified 13 polymorphisms spanning this region two of which (-27307 T/A and -27614 C/A) had allele frequencies greater than 0.05. We further genotyped 111 subjects by applying allele-specific real-time PCR for the -27307 T/A and 27614 C/A polymorphisms, thereby increasing our sample to 129 CAD patients and 108 age- and sex-matched controls. We identified no phenotype-genotype interactions between cases and controls. However, among case subjects the severity of CAD expressed as a mean number of diseased vessels was greater in -27307 A allele carriers and either allele carriers (-27614 A or -27307 A) than in non-carriers (2.56 ± 0.73 vs. 1.83 ± 0.84, adjusted P = 0.027; 2.47 ± 0.74 vs. 1.8 ± 0.83, adjusted P = 0.023). Additionally, either allele carriers (-27614 A or -27307 A) were significantly more common in the multi-vessel disease group (n = 54) than in the single-vessel disease group (n = 75). In conclusion, we reported two new polymorphisms in the distal promoter region of the ST2 gene that possibly influence susceptibility to severe CAD. The functional impact of these polymorphisms remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602249     DOI: 10.1007/s11239-010-0496-y

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  13 in total

1.  Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Authors:  Ellen O Weinberg; Masahisa Shimpo; Gilles W De Keulenaer; Catherine MacGillivray; Shin-ichi Tominaga; Scott D Solomon; Jean-Lucien Rouleau; Richard T Lee
Journal:  Circulation       Date:  2002-12-03       Impact factor: 29.690

2.  Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis.

Authors:  Makiko Shimizu; Akira Matsuda; Ken Yanagisawa; Tomomitsu Hirota; Mitsuteru Akahoshi; Naoko Inomata; Kouji Ebe; Keiko Tanaka; Hisashi Sugiura; Kazuko Nakashima; Mayumi Tamari; Naomi Takahashi; Kazuhiko Obara; Tadao Enomoto; Yoshimichi Okayama; Pei-Song Gao; Shau-Ku Huang; Shin-Ichi Tominaga; Zenro Ikezawa; Taro Shirakawa
Journal:  Hum Mol Genet       Date:  2005-08-23       Impact factor: 6.150

3.  Mutations and differential expression of the ras family genes in human nasal polyposis.

Authors:  Apostolos Zaravinos; John Bizakis; Giannoula Soufla; George Sourvinos; Demetrios A Spandidos
Journal:  Int J Oncol       Date:  2007-11       Impact factor: 5.650

4.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

Authors:  Jochen Schmitz; Alexander Owyang; Elizabeth Oldham; Yaoli Song; Erin Murphy; Terril K McClanahan; Gerard Zurawski; Mehrdad Moshrefi; Jinzhong Qin; Xiaoxia Li; Daniel M Gorman; J Fernando Bazan; Robert A Kastelein
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

Review 5.  T1/ST2--an IL-1 receptor-like modulator of immune responses.

Authors:  Vladimir Trajkovic; Matthew J Sweet; Damo Xu
Journal:  Cytokine Growth Factor Rev       Date:  2004 Apr-Jun       Impact factor: 7.638

6.  Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary intervention.

Authors:  Konstantina Vogiatzi; Stavros Apostolakis; Vassilis Voudris; Sofia Thomopoulou; Georgios E Kochiadakis; Demetrios A Spandidos
Journal:  J Thromb Thrombolysis       Date:  2010-01       Impact factor: 2.300

Review 7.  IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications.

Authors:  Stavros Apostolakis; Konstantina Vogiatzi; Elias Krambovitis; Demetrios A Spandidos
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-04

8.  Soluble ST2 plasma concentrations predict 1-year mortality in acutely dyspneic emergency department patients with pulmonary disease.

Authors:  Abelardo Martinez-Rumayor; Carlos A Camargo; Sandy M Green; Aaron L Baggish; Michelle O'Donoghue; James L Januzzi
Journal:  Am J Clin Pathol       Date:  2008-10       Impact factor: 2.493

9.  Investigations into the role of ST2 in acute asthma in children.

Authors:  M Ali; G Zhang; W R Thomas; C J McLean; J A Bizzintino; I A Laing; A C Martin; J Goldblatt; P N Le Souëf; C M Hayden
Journal:  Tissue Antigens       Date:  2009-03

10.  IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.

Authors:  Shoji Sanada; Daihiko Hakuno; Luke J Higgins; Eric R Schreiter; Andrew N J McKenzie; Richard T Lee
Journal:  J Clin Invest       Date:  2007-05-10       Impact factor: 14.808

View more
  6 in total

Review 1.  Meta-analyses of four eosinophil related gene variants in coronary heart disease.

Authors:  Jiangfang Lian; Yi Huang; R Stephanie Huang; Limin Xu; Yanping Le; Xi Yang; Weifeng Xu; Xiaoyan Huang; Meng Ye; Jianqing Zhou; Shiwei Duan
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

2.  The IL-33-ST2L pathway is associated with coronary artery disease in a Chinese Han population.

Authors:  Xin Tu; Shaofang Nie; Yuhua Liao; Hongsong Zhang; Qian Fan; Chengqi Xu; Ying Bai; Fan Wang; Xiang Ren; Tingting Tang; Ni Xia; Sisi Li; Yuan Huang; Juan Liu; Qing Yang; Yuanyuan Zhao; Qiulun Lv; Qingxian Li; Yue Li; Yunlong Xia; Jin Qian; Bin Li; Gang Wu; Yanxia Wu; Yan Yang; Qing K Wang; Xiang Cheng
Journal:  Am J Hum Genet       Date:  2013-09-26       Impact factor: 11.025

3.  Association of IL33/ST2 signal pathway gene polymorphisms with myocardial infarction in a Chinese Han population.

Authors:  Jin-Hua Yang; Fang-Qin Wu; Qiang Wen; Wen-Cai Zhang; Yang-E Wang; Xin Xiong; Yan-Wen Su; Long-Xian Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-02-12

4.  Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome.

Authors:  Svitlana Demyanets; Walter S Speidl; Ioannis Tentzeris; Rudolf Jarai; Katharina M Katsaros; Serdar Farhan; Konstantin A Krychtiuk; Anna Wonnerth; Thomas W Weiss; Kurt Huber; Johann Wojta
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

5.  Associations between variants in IL-33/ST2 signaling pathway genes and coronary heart disease risk.

Authors:  Fangqin Wu; Mei'an He; Qiang Wen; Wencai Zhang; Jinhua Yang; Xiaomin Zhang; Tangchun Wu; Longxian Cheng
Journal:  Int J Mol Sci       Date:  2014-12-15       Impact factor: 5.923

6.  A functional variant in ST2 gene is associated with risk of hypertension via interfering MiR-202-3p.

Authors:  Fangqin Wu; Lu Li; Qiang Wen; Jinhua Yang; Zhuyue Chen; Peng Wu; Meian He; Xiaomin Zhang; Tangchun Wu; Longxian Cheng
Journal:  J Cell Mol Med       Date:  2017-01-25       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.